US Court orders Guardant to pay $245 million
A U.S. court has ordered Guardant Health to pay more than $245 million in a DNA sequencing patent dispute. The ruling favored TwinStrand Biosciences and the University of Washington. The U.S. District Court for the District of Delaware entered final judgment on August 21. The decision upheld a 2023 jury verdict that found Guardant had […]
We haven't written up this one. Daily Times has the full story — the link below goes straight to it.